Statement on the use nonsteroidal anti-inflammatory drugs in COVID-19 patients
The evidence regarding nonsteroidal anti-inflammatory drugs (NSAIDs) in COVID-19 is similarly lacking. Nonetheless, where short-term fever or pain relief is required, it may be prudent to use drugs from other classes, such as paracetamol. For patients requiring NSAIDs for other indications however, the evidence is not definitive enough to recommend discontinuation. The South African Health Products Regulatory Authority (SAHPRA) has released a communication on the topic of NSAIDs and COVID-19.
Answers extracted from: Clinical management of suspected or confirmed COVID-19 disease (Version 3, 27th March 2020)